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Volume 59, Number 6S Abstracts 83Swere signiﬁcantly different in dissections complicated
by aneurysm formation. Thus, CFD may assist in pre-
dicting which patients may beneﬁt from early stent
grafting.
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Objectives: To describe the association between pres-
sure gradients within fenestrated aortic arch endografts and
the rapid development of in-stent branch stenosis in a
porcine model.
Methods: Ten pigs underwent implantation of a
modular fenestrated stent graft in the aortic arch,
comprising a main, tapered module with branches to the
ascending aorta (AA) and left subclavian artery (LSA).
In group 1 (n ¼ 6), the leading tapered end of the main
module was deployed in the innominate artery (IA) and
the distal, large-caliber end in the descending thoracic
aorta (DTA), orientated so that the fenestrations faced
the AA and LSA. Group 2 (n ¼ 4) animals underwent a
preliminary LSA-to-carotid artery bypass, followed by im-
plantation of a modiﬁed endograft with a larger cross-
sectional area of the fenestration for the ascending aorta
branch module. Pressure gradients between the AA mod-
ule and the endograft at different levels in the arch and
DTA, the IA and LSA were measured intraprocedurally
and at angiography at 1, 3, and 6 months. Pigs were
euthanized after 6 months.
Results: Pressure gradients in the main module, IA,
LSA, and DTA were signiﬁcantly higher in group 1
compared with group 2. Angiograms performed during
the follow-up revealed severe in stent stenosis within
the IA and LSA stents in group 1 animals. No in-stent
stenosis was seen in group 2 branch modules. This
correlated with ﬁndings at gross pathologic and histolog-
ic examination of dense ﬁbrous tissue layer lining the
stent graft in the IA and LSA of group 1 consistent
with intimal hyperplasia.
Conclusions: Elevated pressure gradients observed in
aortic arch endografts appear to be associated with rapid
development of in-stent stenosis in the porcine model,
presumably due to signiﬁcant hemodynamic disturbance.
This potential complication should be taken into consid-
eration when planning experimental arch stent grafts.
Care should be taken to eliminate pressure gradients toavoid development of in-stent stenosis in this animal
model.
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Objectives: Immature plaque neovessels contribute to
atherosclerotic plaque instability and intraplaque hemor-
rhage by leaking erythrocytes and leukocytes in the plaque.
Vascular endothelial growth factor receptor 2 (VEGFR2),
together with the angiopoietin (Ang)-Tie2 system, regulates
the maturation of growing neovessels. We have previously
shown that murine vein graft lesions exhibit massive plaque
neovascularization and that leaky vessels and intraplaque
hemorrhage contribute to lesion growth. We hypothesized
that inhibition of VEGFR2 results in more mature plaque
microvessels and less intraplaque hemorrhage.
Methods: Donor caval veins were engrafted in carotid
arteries of recipient hypercholesterolemic ApoE3*Leiden
mice (n ¼ 14/group). Mice were treated at day 14, 17, 21
and 25 with VEGFR2 blocking antibodies (DC101) or con-
trol immunoglobulin G antibodies (10 mg/kg). At day 28,
mice were euthanized for histologic analysis of the vein grafts.
Results: Morphometric analysis revealed a striking 50%
decrease in vein graft segments that contain leaky vessels in
the DC101-treated group. This was accompanied by a signif-
icant 25-fold decrease in extravasated erythrocytes. Further-
more, lesions that exhibit intraplaque hemorrhage showed
a strong increase in both Ang-1 and Ang-2, indicative for
immature neovessels. VEGFR2 blockade, however, did not
affect the neovessel density in the lesions (control, 52 6 19
neovessels/section; DC101, 63 6 25 neovessels/section).
Interestingly, the vein graft lesion area in the DC101 group
was signiﬁcantly reduced with 32% compared with the con-
trol group. Moreover, plaque stability was clearly increased
in DC101-treated mice, determined by a 50% increase in
collagen content and a 120% increase in SMC content.
Conclusions: Blockade of VEGFR2 leads to reduced
intraplaque hemorrhage, decreased vein graft lesion area,
and increased plaque stability. This identiﬁes plaque neo-
vascularization as an attractive target for the treatment of
unstable atherosclerotic diseases.
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